Evidence map›Paper›PMID 28874344›Full record

ReviewBMJ (Clinical research ed.)2017

Using information technology to improve surveillance of antimicrobial resistance in South East Asia.

Sirenda Vong, Amaury Anciaux, Anette Hulth, John Stelling, Visanu Thamlikitkul, Sunil Gupta, Jonas M Fuks, Kāmini Walia, Pinyo Rattanumpawan, Sergey Eremin and 3 more

Abstract readReview
In one paragraph

Review in BMJ (Clinical research ed.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Key Recommendations for Antimicrobial Resistance Surveillance: Takeaways From the CAPTURA Project.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  7. Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sirenda VongWorld Health Organization, Office of South East Asia region, New Delhi, India vongs@who.int.
Amaury AnciauxWorld Health Organization, Office of South East Asia region, New Delhi, India.
Anette HulthUnit for Antibiotics and Infection Control, Public Health Agency, Stockholm, Sweden (WHO Collaborating Centre for AMR containment).
John StellingWHO Collaborating Centre for Surveillance of Antimicrobial Resistance, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Visanu ThamlikitkulDepartment of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Sunil GuptaNational Centre for Disease Control, India's Ministry of Health and Family Welfare, New Delhi, India.
Jonas M FuksUnit for Antibiotics and Infection Control, Public Health Agency, Stockholm, Sweden (WHO Collaborating Centre for AMR containment).
Kāmini WaliaDivision of Epidemiology and Communicable Diseases, Indian Council of Medical Research, Ansarinagar, New Delhi, India.
Pinyo RattanumpawanDepartment of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Sergey EreminAMR Secretariat, World Health Organization, Geneva, Switzerland.
Klara TisockiEssential Drugs and Medicines, World Health Organization, Office of South East Asia region, New Delhi, India.
Tika R SedaiHealth Emergencies Department, World Health Organization, Office of South East Asia region, New Delhi, India.
Anuj SharmaWorld Health Organization, Office of South East Asia region, New Delhi, India.

Funding

Integrating the world's microbiology laboratories into a global microbial surveillance systemU01CA207167 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI STELLING, JOHN · 2016 to 2018
$1.3M
NCI NIH HHS U01 CA207167
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialInformation TechnologyPublic Health SurveillanceAnimalsAsia, SoutheasternHumansJapanSwedenAnti-Bacterial Agents

Identifiers

PMID28874344
PMCPMC5598292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.